|
Press Releases |
|
|
|
Wednesday, September 6, 2017 |
|
雅各臣發行5億港元可換股票據予Dragons 615 Limited及HH InRe JP, Ltd. |
從事非專利藥及品牌藥品研發、生產、市場推廣及銷售的領先企業─雅各臣科研製藥有限公司(「雅各臣」或「集團」;股份代號:2633)建議按一般授權發行二零二零年到期、本金總額5億港元的可換股票據予兩名認購人,分別為Dragons 615 Limited (「Dragons」,DCP China Credit Fund I, L.P. (「DCP Fund」)之全資擁有的有限公司)及HH InRe JP, Ltd. (「HH JP」,一間由Hillhouse InRe Fund, L.P.間接全資擁有的有限公司)。 more info >> |
|
Jacobson Pharma Issues HK$500M of Convertible Notes to Dragons 615 and HH InRe JP, Ltd. |
Jacobson Pharma Corporation Limited , a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, has proposed to issue Convertible Notes under general mandate, in an aggregate principal amount of HK$500 million due in 2020, to two subscribers namely Dragons 615 Limited and HH InRe JP, Ltd. more info >> |
|
Sunday, June 25, 2017 |
|
雅各臣公布二零一七年全年业绩 |
从事非专利药及品牌药品研发、生产、市场推广及销售的领先企业─雅各臣科研制药有限公司(「雅各臣」或「公司」;股份代号:2633)今天公布公司及附属公司(统称「集团」)截至二零一七年三月三十一日止年度(「二零一七财年」)的全年业绩,亦是公司在去年九月于香港上市后的首份全年业绩。 more info >> |
|
雅各臣公佈二零一七年全年業績 |
從事非專利藥及品牌藥品研發、生產、市場推廣及銷售的領先企業─雅各臣科研製藥有限公司(「雅各臣」或「公司」;股份代號:2633)今天公佈公司及附屬公司(統稱「集團」)截至二零一七年三月三十一日止年度(「二零一七財年」)的全年業績,亦是公司在去年九月於香港上市後的首份全年業績。 more info >> |
|
Jacobson Pharma Announces 2017 Annual Results |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, has today announced its annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2017 ( "FY 2017" ). more info >> |
|
Wednesday, April 26, 2017 |
|
香港李众胜堂保济丸与「水滴无界」签订合作协议 |
李众胜堂(集团)有限公司(「李众胜堂」或「公司」)今天出席「水滴无界」于北京的上线启动仪式,并由代表与「水滴无界」签订合作协议,正式标志着双方展开于中国大陆市场携手合作的新里程。 more info >> |
|
香港李眾勝堂保濟丸與「水滴無界」簽訂合作協議 |
李眾勝堂(集團)有限公司(「李眾勝堂」或「公司」)今天出席「水滴無界」於北京的上線啟動儀式,並由代表與「水滴無界」簽訂合作協議,正式標誌著雙方展開於中國大陸市場攜手合作的新里程。 more info >> |
|
Monday, March 13, 2017 |
|
雅各臣公布收购康宁行70%权益 |
从事非专利药及品牌药品研发、生产、市场推广及销售的领先企业-雅各臣科研制药有限公司(「雅各臣」或「集团」;股份代号:2633)今天公布收购康宁行集团(包括「康宁行有限公司」及其香港附属公司)的70%权益,总代价为56,000,000港元。 more info >> |
|
雅各臣公布收購康寧行70%權益 |
從事非專利藥及品牌藥品研發、生產、市場推廣及銷售的領先企業-雅各臣科研製藥有限公司(「雅各臣」或「集團」;股份代號:2633)今天公佈收購康寧行集團(包括「康寧行有限公司」及其香港附屬公司)的70%權益,總代價為56,000,000港元。完成收購後,康寧行集團將成為雅各臣間接非全資附屬公司。 more info >> |
|
Jacobson Pharma Announces Acquisition of 70% Interest in Hong Ning Hong |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
$9.25 Million in Investments Committed to Start-ups during FinTech World Cup at Dubai FinTech Summit
May 14, 2024 13:02: JST
|
|
|
DENSO and Certhon Introduce Artemy, A Fully Automated Cherry Truss Tomato Harvesting Robot
May 14, 2024 11:02 JST
|
|
|
Creation Business Consultants Expands Presence with New Office in Hong Kong
May 14, 2024 08:30 HKT/SGT
|
|
|
Rover Provides Permitting Update on Let's Go Lithium Project, NV, USA
May 14, 2024 07:00 HKT/SGT
|
|
|
Global News and Publishing Platform Gnomi Launches Paid Journalism Program
May 13, 2024 23:15 HKT/SGT
|
|
|
$9.25 Million in Investments Committed to Start-ups during FinTech World Cup at Dubai FinTech Summit
May 13, 2024 19:58 HKT/SGT
|
|
|
富士通、スーパーコンピュータ「富岳」の世界ランキング結果を発表
May 13, 2024 19:00: JST
|
|
|
Supercomputer Fugaku retains first place worldwide in HPCG and Graph500 rankings
May 13, 2024 18:32 JST
|
|
|
Eisai's Antiepileptic Drug Fycompa Approved in China for Adjunctive Treatment of Primary Generalized Tonic-Clonic Seizures
May 13, 2024 17:06 JST
|
|
|
Datacloud APAC: Charting the Course for APAC's Cloud Future
May 13, 2024 16:00 HKT/SGT
|
|
|
Thailand: Ivy launches plum and tamarind juice drinks in SIG XSlimBloc carton packs
May 13, 2024 15:00 HKT/SGT
|
|
|
3rd Annual Clean Power & New Energy 2024
May 13, 2024 14:03 HKT/SGT
|
|
|
Ogier and TOYOTA GAZOO Racing triumph again
May 13, 2024 14:36 JST
|
|
|
日清食品公布2024年首季度业绩
May 13, 2024 13:00 HKT/SGT
|
|
|
日清食品公布2024年首季度業績
May 13, 2024 12:57 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|